Diligence memo · auto-generated · as of July 3, 2026

Center for Specialty Surgery of Austin, LLC

Center for Specialty Surgery of Austin, LLC looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Center for Specialty Surgery of Austin, LLC operates in Hospitals and Physicians, based in AUSTIN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Center for Specialty Surgery of Austin, LLC has raised $795K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $795K on 2020-07-01.

Most recent recorded round closed around 2020-07-01.

Valuation (modeled)modeled

Provath models Center for Specialty Surgery of Austin, LLC at approximately $23M (range $519K–$258M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.66× the median modeled value of Pre-Seed Hospitals and Physicians companies in 2019–2021 (37 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 6.0 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 30% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 50% of those peers.

Closest niche peers: Newton Dentistry PC, iRemedy PPE2, LLC, iRemedy PPE 4, LLC, Arlington Dental Associates PC, iRemedy PPE 3, LLC.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.